last
year
sinc
discoveri
vanadium
cofactor
found
certain
enzym
tunic
possibl
mammal
differ
vanadiumbas
drug
develop
target
treat
differ
patholog
far
vitro
studi
insulin
mimet
antitumor
antiparasit
activ
certain
compound
vanadium
result
great
boom
inorgan
bioinorgan
chemistri
chemic
speciat
studi
vanadium
amino
acid
control
condit
even
blood
plasma
essenti
understand
biotransform
eg
vanadium
antidiabet
complex
physiolog
level
provid
clue
mechan
action
present
articl
carri
bibliograph
research
emphatic
chemic
speciat
vanadium
differ
amino
acid
review
also
import
aspect
chemistri
therapeut
applic
sever
vanadium
complex
vanadium
gray
metal
element
z
center
cubic
lattic
due
high
melt
point
consid
refractori
metal
metal
locat
first
transit
seri
period
tabl
specif
group
group
vb
metal
form
electron
configur
ar
v
ii
v
iii
v
iv
v
v
common
oxid
state
vanadium
consid
rel
abund
element
fact
soil
water
deposit
atmospher
abund
around
repres
approxim
concentr
mgkg
soil
abund
transit
metal
present
soil
exceed
vanadium
contain
univers
factor
time
ocean
approxim
concentr
around
nm
exist
mainli
ionic
pair
form
n
h
vo
n
repres
cation
dissolv
seawat
surpass
molybd
moo
ion
around
nm
abund
transit
metal
ocean
sweet
water
human
consumpt
exampl
concentr
v
around
nm
howev
volcan
zone
concentr
vanadium
water
level
around
lm
frequent
high
concentr
bring
consequ
contamin
aquif
geochem
characterist
vanadium
depend
mainli
two
factor
oxid
state
ph
henc
reduct
condit
speci
base
v
iii
predomin
sinc
higher
oxid
state
solubl
human
bodi
concentr
vanadium
around
lm
remain
balanc
amount
vanadium
excret
consum
daili
food
drink
intak
histor
discoveri
vanadium
done
manuel
del
examin
lead
miner
obtain
zimapan
mexico
initi
rio
call
erythronium
red
due
red
color
impart
salt
heat
howev
french
chemic
societi
consid
rio
discov
new
chemic
element
instead
found
impur
chromium
identif
vanadium
occur
sefstrom
isol
miner
extract
mine
taberg
sweden
vanadium
owe
name
vanadi
scandinavian
goddess
love
beauti
fertil
multicolor
compound
natur
vanadium
found
differ
miner
common
patronit
v
sn
roscoelit
mg
fe
bravonit
fe
ni
v
davidit
titan
fe
u
v
cr
rare
earth
sulvanit
vanadit
pb
vo
cl
carnotit
k
v
also
found
porphyrin
present
exampl
venezuelan
heavi
extra
heavi
crude
oil
concentr
rang
vanadium
crude
oil
shown
tabl
obtain
vo
porphyrin
two
isotopicform
v
v
v
slightli
radioact
halflif
year
vanadiumporphyrin
form
earli
diagenesi
sourc
rock
rel
abund
vanadium
relat
deposit
environ
worldwid
vanadium
main
sourc
locat
australia
brazil
china
finland
india
new
zealand
russia
south
africa
sweden
usa
venezuela
vanadium
either
pure
metal
alloy
form
show
particular
risk
human
health
howev
vanadium
react
violent
certain
materi
brf
chlorin
lithium
strong
acid
addit
powder
form
present
moder
risk
fire
nevertheless
certain
vanadium
compound
report
irrit
mucosa
prolong
exposur
may
lead
complic
pulmonari
level
gener
patholog
tend
chronic
exampl
report
ld
v
rat
mg
kg
vanadiumintox
occur
particularli
inhal
vanadiumrich
powder
symptom
similar
present
influenza
mani
metal
ion
element
tend
interact
biomolecul
form
coordin
bond
describ
pearson
theori
hard
soft
acid
base
surpris
natur
evolut
incorpor
certain
metal
ion
fulfil
within
essenti
biolog
process
physiolog
level
biolog
interest
vanadium
lie
abil
particip
differ
process
mention
exampl
found
activ
site
haloperoxidas
nitrogenas
counter
ion
dna
rna
addit
particip
photocleavag
protein
insulin
regul
process
wherea
certain
vanadium
compound
sodium
vanad
bi
maltolalo
oxovanadium
iv
exhibit
insulinlik
activ
vanadium
compound
exhibit
antiparasit
activ
potenti
antitumor
agent
thu
studi
vanadium
respect
compound
great
import
bioinorgan
medicin
inorgan
chemistri
sinc
allow
obtain
possibl
therapeut
treatment
differ
patholog
hope
inform
use
guid
futur
research
area
knowledg
main
goal
review
two
carri
bibliograph
research
chemic
speciat
binari
ternari
complex
vanadium
non
essenti
aamino
acid
collect
inform
promin
applic
vanadium
compound
especi
vanadium
complex
non
essenti
amino
acid
pharmacolog
therapeut
applic
well
import
bioinorgan
chemistri
vanadium
metal
element
smooth
ductil
pure
metal
rel
inert
oxygen
nitrogen
hydrogen
room
temperatur
also
good
resist
corros
process
water
salt
dilut
solut
hcl
h
alkalin
solut
easili
oxid
temperatur
vanadium
mainli
obtain
byproduct
mine
byproduct
product
uraniumvanadium
product
phosphoru
ferrophosphoru
oilproduc
countri
canada
venezuela
vanadium
obtain
crude
oil
tabl
variat
vanadium
abund
oil
oil
type
v
light
oil
nonmarin
crude
oil
marin
heavi
biodegrad
oil
bitumen
marin
rosco
first
one
isol
vanadium
almost
pure
form
hydrogen
reduct
vanadium
dichlorid
vcl
current
vanadium
obtain
reduct
vanadium
trichlorid
magnesium
magnesiumsodium
mixtur
vanadium
also
extract
leach
water
precipit
ph
sodium
hexavanad
na
v
obtain
red
precipit
addit
sulfur
acid
howev
vanadium
produc
industri
level
obtain
modif
mckechnieseybair
process
consist
reduc
v
calcium
pressur
purif
vanadium
tend
difficult
sinc
easili
contamin
element
process
carri
either
calcium
reduct
iodid
refin
via
van
arkeldebo
process
thermal
decomposit
solvent
extract
electrolyt
refin
molten
salt
achiev
puriti
one
import
develop
u
bureau
mine
extract
vanadium
heavi
extraheavi
crude
oil
electrodeposit
process
consist
cathod
deposit
vanadium
solut
vcl
eutect
mixtur
kcllicl
fuse
salt
temperatur
mean
method
possibl
obtain
vanadium
degre
puriti
vanadium
also
use
nuclear
applic
use
alloy
fe
co
ni
v
coat
fuel
element
reactor
provid
good
structur
strength
high
temperatur
resist
corros
action
liquid
sodium
furthermor
small
cross
section
neutron
fission
addit
develop
intermetal
compound
vanadium
use
construct
superconduct
magnet
present
critic
current
highest
valu
obtain
known
materi
provid
magnet
field
g
one
import
vanadiumcompound
industri
applic
vanadium
pentoxid
v
use
catalyst
mani
industri
process
manufactur
ceram
product
maleic
anhydrid
catalyz
oxid
butan
air
product
phthalic
anhydrid
oxid
oxylen
naphthalen
product
adip
acid
oxal
acid
anthraquinon
v
also
use
product
sulfur
acid
due
effici
convert
also
use
catalyst
compon
select
heterogen
catalyt
reduct
x
eman
mani
industri
plant
vanadium
complex
present
differ
biolog
system
mani
occas
form
complex
protein
transferrin
albumin
hemoglobin
aamino
acid
import
complex
identif
character
given
chemic
speciat
possibl
binari
ternari
vanadium
complex
form
differ
aamino
acid
fact
sinc
late
great
interest
metabol
reaction
vanadiumamino
acid
compound
thu
differ
amino
acid
reaction
biolog
system
catalyz
enzym
contain
pyridox
phosphat
enzymat
reaction
model
format
schiff
base
produc
condens
aromat
aldehyd
aamino
acid
hand
vanadium
nsalicylideneamino
acid
complex
use
model
system
studi
enzymecatalyz
reaction
contain
pyridox
fig
show
format
schiff
base
pyridoxalderiv
aamino
acid
regard
vanadiumamino
acid
system
throughout
literatur
found
sever
studi
chemic
speciat
binari
ternari
complex
studi
mainli
carri
potentiometr
techniqu
epr
electron
paramagnet
reson
v
iv
compound
nmr
nuclear
magnet
reson
v
v
compound
uvvis
molecular
absorpt
circular
dichroism
differ
concentr
use
differ
ionic
media
vanadium
form
dival
cation
studi
lack
interest
biolog
system
ion
oxid
faster
higher
oxid
state
fact
aqueou
solut
v
ii
reduc
water
hydrogen
nevertheless
v
ii
complex
saccharin
ligand
success
character
cotton
group
highlight
stabil
complex
v
c
h
h
v
c
h
no
py
case
complex
present
octahedr
geometri
four
molecul
water
pyridin
depend
studi
surround
vanadium
atom
protect
metal
center
provid
enough
stabil
obtain
xrd
xray
diffract
structur
v
iii
ion
one
hand
hydrolyz
aqueou
solut
form
mononuclear
polynuclear
speci
ph
close
neutral
trimer
v
oh
becom
predomin
v
iii
complex
biogen
ligand
possess
donor
sulfur
atom
aqueou
solut
hydrolys
high
ph
valu
may
form
polynuclear
speci
v
iii
complex
lcystein
lalanin
laspart
acid
lglutam
acid
lhistidin
among
amino
acid
small
blood
serum
bioligand
studi
evidenc
concentr
ph
depend
solut
shown
fig
speciat
studi
v
iii
glycin
v
iii
cystein
system
report
format
speci
v
iii
l
vl
vl
l
l
correspond
glycin
cystein
respect
note
vl
vl
complex
two
molecul
lcystein
coordin
v
iii
amino
carboxyl
thiolat
group
solut
vanadium
iii
lcystein
ph
lm
administr
cultur
medium
hepatoma
morri
grow
cell
show
cytotox
effect
solut
toward
tumor
cell
viabil
cell
reduc
lm
vanadium
speci
fig
format
reaction
schiff
base
act
intermediari
speci
reaction
catalyz
enzym
contain
pyridox
modifi
ref
concentr
cultur
medium
studi
show
v
iii
cystein
complex
also
exhibit
significantli
greater
total
antioxid
capac
high
inhibit
neutral
endopeptidas
nep
concentr
high
lung
prevent
lung
metastasi
test
wistar
rat
section
describ
mechan
action
antitumor
activ
vanadium
iii
lcystein
complex
studi
ternari
complex
format
vanadium
iii
cystein
small
blood
serum
bioligand
eg
lactic
oxal
phosphor
citric
acid
show
exampl
presenc
lactat
two
complex
form
v
cy
lac
v
cy
lac
oh
last
one
import
ph
combin
citrat
oxal
complex
detect
ph
v
cy
cit
v
cy
ox
respect
vanadium
iii
h
cysh
po
system
two
complex
detect
v
cy
h
po
v
cy
hpo
second
one
abund
ph
studi
also
show
system
v
iii
cy
laccit
ternari
complex
stabl
binari
one
detriment
system
v
iii
cy
hpo
ox
binari
complex
stabl
ternari
one
model
studi
aqueou
solut
dipicolin
acid
dipic
lcystein
cy
lhistidin
laspart
asp
lglutam
glu
acid
show
speci
present
tabl
best
experiment
theoret
fit
emf
h
data
fig
repres
distribut
speci
diagram
v
iii
dipicci
v
iii
dipichi
system
chemic
equilibria
complex
process
v
iii
lalanin
ala
laspart
acid
asp
aqueou
solut
show
lalanin
form
mononuclear
speci
ml
speci
l
repres
v
iii
aamino
acid
respect
predomin
ph
lalanin
act
bidend
ligand
n
atom
laspart
acid
complex
process
show
complic
exampl
ph
similar
lalanin
higher
ph
region
form
mono
variou
dinuclear
speci
carboxyl
loxo
bridg
differ
number
coordin
ligand
oh
group
nevertheless
v
iii
laspart
acid
v
iii
lalanin
complex
signific
apoptot
effect
hepatoma
morri
cell
complex
compound
vanadium
iii
lhistidin
instead
show
solut
ph
consecut
mononuclear
speci
mlh
ml
h
mlh
ml
h
ml
form
higher
ph
mix
hydroxyandor
oxospeci
appear
solut
ph
rang
v
ol
speci
predominantli
exist
solut
import
note
ml
n
h
repres
differ
binari
complex
metal
center
l
n
n
aamino
acid
coordin
vanadium
h
acid
proton
aamino
acid
act
ligand
v
iii
complex
suscept
oxid
v
iv
also
easili
oxidaz
v
v
time
import
highlight
speciat
studi
v
iii
describ
far
done
strict
absenc
oxygen
speciat
done
ph
fig
consid
approxim
reason
biolog
effect
observ
vitro
studi
evalu
effect
v
iii
complex
hepatoma
morri
cell
may
due
v
iv
andor
v
v
complex
obtain
oxid
initi
compound
present
review
point
studi
vanadium
interact
amino
acid
lcystein
lhistidin
lglycin
among
blood
serum
compon
phosphat
lactat
oxal
citrat
fig
speci
distribut
diagram
system
v
iii
h
cythpro
kcl
use
molar
ratio
r
metal
concentr
modifi
ref
h
cyt
hpro
repres
citric
acid
prolin
respect
ternari
speci
present
best
experiment
theoret
fit
emf
h
data
studi
system
fig
speci
distribut
diagram
system
v
iii
h
dipich
cy
kcl
b
speci
distribut
diagram
system
v
iii
h
dipichhi
kcl
case
molar
ratio
r
use
v
iii
concentr
medium
modifi
ref
import
bioligand
media
howev
would
also
import
studi
know
complex
system
v
ion
reduct
compon
present
blood
serum
glutathion
thiol
ascorb
oxid
compon
molecular
oxygen
hydrogen
peroxid
v
iv
ion
hand
exist
pure
ion
aqueou
solut
media
much
stabl
oxidovanadium
v
vo
time
longer
v
iii
oxid
v
v
vo
differ
speci
depend
expect
ph
solut
total
concentr
v
iv
seen
fig
also
form
ph
valu
howev
circular
dichroism
uv
epr
spectroscopi
studi
solut
contain
amino
acid
shown
predomin
speci
ph
v
iv
oh
n
n
depend
total
concentr
vanadium
iv
import
mention
rel
abund
speci
v
iv
oh
v
iv
oh
n
also
depend
total
v
iv
oxid
concentr
nevertheless
stabil
constant
v
iv
oh
n
difficult
determin
ph
predomin
speci
v
iv
oh
corrobor
optic
raman
epr
spectroscopi
differ
studi
show
stabil
constant
vanadium
iv
complex
ph
logb
hydrolyt
process
extens
import
even
presenc
high
molar
ratio
amino
acid
vol
complex
l
bident
monoanion
ligand
strongli
influenc
natur
link
atom
size
metallacycl
form
mani
studi
found
literatur
system
v
iv
amino
acid
despit
complex
produc
hydrolysi
reaction
metal
equilibrium
model
establish
potentiometr
data
visibl
absorpt
epr
circular
dichroism
model
studi
aqueou
solut
v
iv
amino
acid
lalanin
ala
lserin
ser
lthreonin
thr
lglycin
gli
lhistidin
laspart
asp
lglutam
glu
acid
lcystein
cy
show
speci
present
tabl
gave
best
fit
experiment
data
import
applic
v
compound
medicin
use
antidiabet
drug
bloodstream
v
speci
undergo
manifold
process
ligand
exchang
redox
complex
reaction
v
iv
speci
absorb
gastrointestin
tract
move
serum
encount
mani
low
molecular
mass
lmm
bioligand
citrat
lactat
phosphat
amino
acid
etc
protein
transferrin
htf
albumin
hsa
immunoglobulin
ig
final
form
depend
affin
variou
bioligand
rel
concentr
garribba
et
al
mean
epr
spectroscopi
studi
complex
v
iv
ion
sever
system
well
ion
transport
blood
serum
physiolog
condit
studi
consid
ternari
system
form
anoth
research
base
blood
serum
system
studi
biotransform
four
insulinenhanc
vanadium
compound
pic
acac
dhp
repres
deproton
form
carrier
ligand
picolin
acid
acetylaceton
pyridinon
respect
also
studi
behavior
insulinenhanc
speci
human
serum
apotransferrin
htf
human
serum
albumin
hsa
lactat
lact
citrat
cyt
physiolog
ph
result
indic
ligand
coordin
weakli
metal
center
carrier
ligand
interact
way
v
iv
ion
intak
cell
v
iv
interact
strongli
coordin
ligand
pic
acac
dhp
v
iv
transport
transferrin
also
v
iv
carrier
mix
speci
v
iv
ohtfcarri
albumin
particip
transport
insulinenhanc
compound
form
mix
speciescisv
iv
carrier
hsa
kiss
et
al
also
studi
interact
v
iv
ion
human
serum
albumin
hsa
epr
circular
dichroism
cd
uvvis
spectroscopi
experiment
result
reveal
v
iv
occupi
two
type
bind
site
albumin
compet
also
hydrolysi
metal
ion
studi
ternari
system
v
iv
ohsal
l
repres
ligand
drug
candid
maltol
mal
picolin
acid
pic
hpno
pyridinon
dhp
indic
system
mal
pic
hpno
dhp
ternari
speci
v
iv
ol
n
hsa
form
maximum
valu
n
mal
pic
speci
v
iv
ol
n
hsa
exclus
detect
pic
base
spectroscop
studi
propos
speci
v
iv
ol
n
hsa
protein
bound
vanadium
histidin
side
chain
degre
format
ternari
speci
correspond
reaction
v
iv
ol
hsa
v
iv
ol
hsa
hpno
pic
mal
dhp
garribba
note
hl
denot
amino
acid
h
l
case
cystein
appli
also
cy
glu
asp
ml
n
h
oh
r
denot
differ
binari
complex
metal
nucleu
v
iv
l
n
repres
aamino
acid
total
deproton
form
case
coordin
vanadium
oh
r
hydroxi
substitu
came
hydrolysi
h
molecul
coordin
metal
center
h
proton
acid
aamino
acid
act
ligand
ternari
speci
gave
best
fit
experiment
data
v
note
hl
denot
amino
acid
h
l
case
cystein
appli
also
cy
glu
asp
ml
n
h
oh
r
denot
differ
binari
complex
metal
nucleu
v
iv
l
n
repres
aamino
acid
total
deproton
form
case
coordin
vanadium
oh
r
hydroxi
substitu
came
hydrolysi
h
molecul
coordin
metal
center
h
proton
acid
aamino
acid
act
ligand
indic
neutral
compound
penetr
erythrocyt
membran
passiv
diffus
found
intracellular
medium
amount
higher
altern
insid
red
blood
cell
compound
v
iv
mal
final
studi
concern
transport
vanadium
complex
blood
conclud
vanadium
complex
mostli
transport
transferrin
htf
low
micromolar
concentr
assum
v
iv
maintain
oxid
state
complex
hydrolys
vanadium
iv
transport
vo
htf
v
iv
bound
one
iron
site
hand
vanadiumpyridox
complex
seek
mimic
biolog
system
catalyz
pyrodox
phosphat
enzym
among
other
emul
system
format
schiff
base
condens
appropri
aromat
aldehyd
amino
acid
favor
presenc
metal
case
pyridox
act
bident
ligand
maintain
planar
system
addit
pessoa
et
al
propos
seri
possibl
reaction
activ
vanadium
onsalicylideneimin
acid
complex
reaction
catalyz
pyridox
enzym
fig
show
seri
reaction
system
v
iv
osalci
good
exampl
vanadium
onsalicylideneimin
acid
complex
activ
two
reaction
side
group
remov
desulphydr
cystein
deamin
system
complex
vo
salci
h
form
complex
fig
suffer
desulphydr
step
produc
h
dehydroalanin
complex
b
complex
fig
reaction
proce
decomposit
schiff
base
ligand
amino
acid
produc
eg
nh
pyruv
acid
character
xray
diffract
identifi
b
fig
one
counter
ion
decavanad
moieti
mechan
pyridin
attack
bcarbon
atom
tryptophan
molecul
elimin
side
attack
pyridin
molecul
bcarbon
atom
tryptophan
process
side
group
would
bind
bcarbon
atom
would
lead
racem
amino
acid
see
fig
modifi
ref
group
trp
produc
complex
c
fig
may
react
proton
yield
complex
nsalicylideneglycin
system
v
iv
osalph
complex
v
iv
sallph
h
sallph
nsalicylidenelphenylalanin
dissolv
mixtur
solvent
waterpyridin
form
crystal
dimer
v
v
py
lc
oxal
act
symmetr
bi
chelat
bridg
oxal
result
reduct
coupl
co
decarboxyl
product
amino
acid
vanadyl
n
n
bi
salicyliden
ophenylen
diamin
salophen
complex
character
cyclic
voltammetri
uvvis
spectroscopi
theoret
calcul
mecn
acetonitril
thf
tetrahydrofuran
dmf
n
ndimethylformamid
expect
complex
structur
base
experiment
evid
shown
fig
fig
show
vanadium
mono
nuclear
complex
onsalicylideneimin
acid
structur
elucid
xray
diffract
wherea
tabl
present
summari
vanadium
complex
least
one
part
ligand
model
pyridox
structur
report
character
epr
uvvi
cd
nmr
xrd
complex
vo
pyrd
lile
bipi
vanadium
schiffbas
complex
contain
amino
acid
pyridox
character
xrd
aqueou
chemistri
v
v
great
interest
ration
drug
design
sinc
vanad
deriv
speci
structur
analog
phosphat
import
fig
xrd
structur
obtain
vanadium
onsalicylieneamino
acidato
complex
modifi
ref
tabl
sever
vanadiumpyridox
complex
structur
studi
magnet
spectroscop
techniqu
ref
vanadium
biolog
system
involv
extens
number
biolog
recognit
biocatalyt
system
pourbaix
represent
fig
diagram
rel
abund
differ
speci
depend
potenti
function
ph
differ
system
aqueou
phase
show
v
iv
stabl
speci
solut
low
ph
v
v
predomin
high
ph
ph
major
vanad
v
speci
decamer
compound
v
variou
proton
form
speci
thermodynam
unstabl
ph
ph
decavanad
form
studi
base
v
nmr
shown
colorless
solut
oxovanad
concentr
mm
neutral
alkalin
ph
monom
vanadium
dimer
trimer
tetram
pentam
form
coexist
biolog
effect
vanadium
especi
v
iv
v
v
ion
partli
due
abil
form
stabl
complex
larg
number
biogen
ligand
ligand
maltol
lactat
citrat
last
two
present
blood
serum
averag
concentr
lactat
mm
citrat
speciat
system
vanad
v
maltol
complex
ph
despit
vanad
v
form
complex
acid
ph
reduct
v
iv
may
occur
pettersson
et
al
studi
system
neutral
slightli
alkalin
solut
blood
serum
physiolog
ph
ph
use
potentiometri
v
nmr
epr
experiment
condit
reduct
may
also
occur
although
rather
low
rate
allow
detail
studi
system
determin
speciat
vanadatemaltol
system
speciat
diagram
present
fig
abund
speci
physiolog
ph
vo
maltol
complex
lactat
lac
use
ligand
complex
favor
acid
condit
fig
show
distribut
speci
diagram
vanadatelact
system
abund
lactat
vanadium
v
speci
acid
media
complex
v
lac
v
lac
v
short
design
oxido
dioxidovanadium
center
physiolog
ph
vlac
exist
speci
hydrogen
peroxid
ad
medium
speciat
diagram
show
fig
complex
v
lac
abund
lactato
speci
physiolog
ph
vanadatecitr
system
speci
distribut
diagram
fig
indic
speci
form
physiolog
ph
complex
v
cyt
wherea
vanadatelactatecitr
system
acid
ph
format
binuclear
speci
v
cytlac
n
detect
n
valu
vanad
phosphat
structur
analog
similar
behavior
expect
speci
context
explor
potenti
biolog
activ
adenosylvanad
analog
adenosylphosph
speciat
studi
done
evalu
interact
vanad
adenosin
aqueou
solut
includ
imidazol
im
one
build
unit
adenosin
ad
experiment
result
reveal
binari
system
vanadateadb
fig
ph
main
speci
solut
binuclear
complex
vo
ad
ternari
system
vanadateadim
fig
mononuclear
complex
vo
im
ad
detect
speciat
vanadatepicolin
acid
pic
system
studi
potentiometr
titrat
v
nmr
shown
fig
analysi
indic
format
complex
vpic
wide
ph
rang
spectroscop
studi
v
nmr
reveal
abund
speci
form
ph
three
geometr
isom
vpic
fig
v
iv
v
v
possibl
v
iii
chemistri
relev
blood
stream
thought
presenc
reduc
agent
eg
ascorb
acid
cystein
could
effect
reduc
v
v
v
iv
nevertheless
presenc
molecul
blood
may
lead
oxid
v
v
thu
equilibrium
establish
v
iv
v
v
speci
studi
physiolog
ph
ionic
strength
histidin
hhisoh
vanad
show
form
least
two
weak
complex
amino
group
ligand
amino
acid
peptid
lysin
glutam
acid
glycin
glycylglycin
show
weak
vanad
interact
similar
affin
vo
cation
use
vn
mr
spectroscopi
establish
equilibria
diperoxovanad
number
diand
tripeptid
glycyltyrosin
glycylserin
glycylthreonin
glycylglutam
acid
glycyllysin
glycyltryptophan
tryptylglycin
tryptyltryptophan
tryptyltyrosin
glycylglycylserin
tyrosylglycylglycin
tryptylglycylglycin
aqueou
solut
complex
character
ml
speci
l
repres
dior
tripeptid
diperoxo
vanad
system
vanadateglycylglycin
vanadatealanylglycin
vanadateprolylalanin
vanadatealanylhistidin
studi
potentiometr
titrat
v
nmr
spectroscopi
model
best
adjust
experiment
data
indic
format
ternari
speci
h
p
h
vo
q
l
r
system
equilibria
studi
written
compon
h
h
vo
l
thu
complex
form
accord
complex
often
given
notat
p
q
r
h
vo
glycylglycin
h
vo
alanylhistidin
p
q
r
valu
respect
suggest
format
two
complex
everi
system
instead
h
vo
alanylglycin
h
vo
prolylalanin
complex
p
q
r
valu
indic
format
one
complex
system
tabl
indic
formul
complex
v
v
dior
tripeptid
v
iv
dior
tripeptid
analyz
xrd
phen
repres
phenanthrolin
studi
v
v
apotransferrin
blood
plasma
glycoprotein
show
protein
abl
bind
two
v
v
similarli
metal
ion
stabil
constant
apotfv
v
interact
order
magnitud
higher
inorgan
anion
phosphat
sulfat
hydrogen
carbon
also
evid
coordin
metal
apotf
two
tyrosin
side
chain
upon
investig
carri
group
pettersson
dipeptid
proala
alagli
alahi
alas
tent
structur
complex
dipeptid
propos
depict
fig
due
multipl
biolog
interest
oxovanadium
system
amino
acid
schiff
base
deriv
amino
acid
peptid
also
extens
investig
pessoa
et
al
studi
system
v
iv
oglycylglycin
v
iv
oglycylglycylglycin
v
iv
oglycylaspart
acid
v
iv
oglutathion
v
iv
ooxid
glutathion
use
potentiometr
titrat
spectroscop
analysi
uvvis
absorpt
epr
circular
dichroism
tabl
show
speciat
model
propos
best
fit
experiment
data
ph
qm
rl
soh
group
conform
complex
q
l
r
h
p
oh
l
denot
vo
schiff
base
deriv
amino
acid
respect
p
q
r
denot
stoichiometr
coeffici
group
conform
complex
hand
tabl
acid
glycin
v
iv
osalgli
tabl
base
speciat
model
propos
best
fit
experiment
data
ph
qm
rl
soh
group
conform
complex
q
l
r
h
p
oh
l
denot
vo
dipeptid
tripeptid
respect
p
q
r
denot
stoichiometr
coeffici
group
conform
complex
form
nh
n
n
coo
donor
set
hisglygli
nh
n
n
n
im
glyglyhi
nh
n
n
glyglyci
previou
section
describ
import
vanadium
industri
level
chemic
speciat
binari
ternari
complex
amino
acid
briefli
import
biolog
level
studi
chemic
speciat
aqueou
solut
fundament
know
natur
abund
stabil
differ
speci
solut
repres
essenti
requir
evalu
biolog
activ
promis
therapeut
target
section
discuss
applic
vanadium
compound
especi
vanadium
complex
non
essenti
amino
acid
pharmacolog
medic
therapeut
well
import
bioinorgan
chemistri
metal
compound
use
medicin
applic
sinc
ancient
time
howev
use
drug
organ
origin
govern
develop
modern
medic
chemistri
discoveri
cisplatin
exampl
potent
antitumor
activ
led
mani
research
worldwid
focu
studi
inorgan
medic
chemistri
fact
coordin
chemistri
compound
organometal
compound
use
differ
metal
center
evalu
cancer
endem
tropic
diseas
chaga
leishmaniasi
viral
infect
dengu
sar
hiv
although
report
applic
vanadium
eighteenth
centuri
biolog
import
vanadium
recogn
earli
show
fungostat
effect
yeast
howev
interest
bioinorgan
vanadium
chemistri
becam
notabl
late
cantley
cowork
report
inhibit
na
k
atpas
vanad
disclos
biolog
consequ
chemic
similar
vanad
v
ion
phosphat
fundament
differ
vanad
v
phosphat
type
reaction
particip
eg
v
andor
p
ester
format
acidbas
equilibria
physiolog
ph
vanad
v
mainli
h
vo
form
phosphat
present
h
po
hpo
approxim
equal
concentr
phosphat
present
transit
state
pentacoordin
wherea
vanad
v
easili
reach
coordin
number
five
acquir
distort
trigon
bipyramid
geometri
caus
vanad
oxovanadium
cluster
compound
inhibit
phosphatas
phosphorylas
alkalin
phosphatas
acid
phosphatas
tyrosineprotein
phosphatas
ribonucleas
phosphordiesteras
phosphoglucomutas
differ
effici
activ
phosphatedepend
enzym
may
inhibit
vanad
incorpor
activ
site
replac
phosphat
thu
interact
vanad
v
protein
occur
bind
moieti
similar
form
phosphat
one
exampl
interact
phosphoryl
tyrosin
residu
vanad
v
also
form
ester
tyr
residu
mimick
phosphoryl
process
vanadium
consider
electrophil
phosphor
vo
bond
vanad
longer
correspond
po
bond
phosphat
po
bond
coval
respect
vo
bond
differ
meaning
simpl
geometr
calcul
done
volum
vanad
show
increas
rel
phosphat
assum
similar
molecular
geometri
highlight
small
molecul
squar
pyramid
geometri
common
presenc
protein
trigon
bipyramid
better
support
comparison
molecular
geometri
vanad
phosphat
relev
sever
protein
shown
fig
vanad
identifi
moieti
may
bind
activ
site
certain
enzym
protein
phosphatas
tabl
binari
speci
v
iv
oschiff
base
deriv
amino
acid
peptid
l
denot
vo
schiff
base
deriv
amino
acid
respect
v
iv
oglycylglycin
v
iv
oglycylglycylglycin
v
iv
oglycylaspart
acid
protein
tyrosin
phosphatas
vanadium
form
coordin
penta
hexa
complex
involv
bident
bond
carboxyl
group
aspart
enzym
play
crucial
role
signal
insulin
receptor
neg
regul
pathway
fact
antidiabet
activ
vanadium
compound
link
format
transit
state
stabl
analogu
bind
strongli
activ
site
lead
inhibit
unlik
phosphoest
vanad
ester
bound
activ
site
enzym
easili
releas
caus
inhibit
ptp
activ
lyonnet
et
al
observ
first
time
oral
administr
na
vo
decreas
glycosuria
diabet
patient
present
inhibit
propos
main
insulinmimet
target
signific
number
vanadium
complex
investig
antidiabet
potenti
nevertheless
reduc
v
v
v
iv
possibl
revers
inhibit
reach
presenc
glutathion
andor
biolog
reduc
agent
import
vanadiumenzym
complex
vanadium
bromoperoxidas
vbpo
one
first
enzym
discov
use
vanadium
cofactor
vanadium
nitrogenas
vnase
found
nitrogenfix
bacteria
genu
azotobact
chroococcumvinelandii
well
known
vanadium
expand
sphere
coordin
easili
switch
differ
state
oxid
given
physiolog
environ
common
oxid
state
vanadium
oxid
state
iii
iv
v
found
involv
biolog
system
sinc
v
ii
abl
reduc
water
hydrogen
common
oxid
state
vanadium
biolog
system
especi
mammal
v
v
v
iv
sinc
v
iii
suscept
oxid
process
howev
stabl
v
iii
transferrin
human
complex
found
addit
presenc
v
iii
final
storag
stage
ascidian
concentr
v
reach
valu
mm
v
use
venom
potenti
predat
vanadium
compound
origin
consid
mani
year
potenti
oral
drug
treatment
patient
diabet
mellitu
howev
develop
insulin
interest
metalbas
drug
decreas
end
insulinlik
effect
vanadium
compound
sever
experiment
model
consolid
among
stimul
glucos
transport
glycolysi
glycosynthesi
among
carbohydr
metabol
event
inorgan
salt
navo
voso
consid
treatment
diabet
inorgan
salt
present
sever
problem
gastrointestin
distress
low
absorpt
reason
studi
inorgan
salt
vanadium
discard
newer
research
made
toward
complex
v
iv
bident
organ
ligand
maltolato
dmpp
nate
picolin
special
attent
later
one
sinc
picolin
acid
intermedi
metabolit
tryptophan
therefor
less
toxic
mammal
organ
promot
well
absorpt
variou
metal
small
intestin
chelat
effect
carrier
ligand
greatli
influenc
effici
compound
determin
readsorpt
improv
biodistribut
stabil
toler
metal
ion
organ
one
import
compound
bi
ethylmaltol
oxovana
dium
iv
beov
akesi
pharmaceut
inc
suspend
phase
ii
due
problem
despit
good
clinic
efficaci
patient
type
diabet
v
iv
dmpp
bi
oxovanadium
iv
complex
exhibit
antidiabet
activ
increas
glucos
uptak
adipocyt
promot
phosphoryl
key
protein
insulin
signal
chronic
vivo
treatment
v
iv
dmpp
decreas
hyperglycemia
improv
glucos
toler
observ
studi
system
markedli
enhanc
lipogenesi
glucos
uptak
rat
adipocyt
latter
effect
relat
increas
transloc
addit
fig
comparison
geometri
vanad
phosphat
relev
physiolog
level
modifi
ref
activ
complex
lipid
carbohydr
metabol
block
wortmannin
known
inhibitor
phosphoinositid
thu
consolid
mimic
effect
expect
treatment
rat
streptozotocininduc
diabet
show
greater
hypoglycem
effect
compar
navo
karmak
et
al
show
vanadium
complex
polycglutam
acid
vocpga
polym
nonessenti
amino
acid
produc
hypoglycem
effect
decreas
glycosyl
hemoglobin
level
improv
glucos
toler
streptozotocininduc
type
diabet
mice
kka
mous
model
diabet
type
ftir
epr
studi
show
vo
coordin
carboxyl
group
chain
form
two
form
complex
carboxyl
vo
oh
orand
carboxyl
vo
oh
studi
conduct
hu
et
al
show
vocpga
improv
marker
renal
hepat
damag
diabet
rat
compar
voso
likewis
complex
decreas
triglycerid
blood
fatti
acid
alloxan
induc
diabet
rat
worth
mention
one
main
undesir
consequ
inorgan
vanadium
intak
effect
lipid
metabol
still
unclear
exampl
healthi
rat
treat
via
oral
voso
observ
increas
total
cholesterol
ldl
blood
triglycerid
fact
patient
impair
glucos
toler
treat
voso
show
increment
basal
triglycerid
level
mmoll
p
treatment
inorgan
vanadium
patient
studi
exhaust
respect
lipid
metabol
given
elev
blood
level
triglycerid
cholesterol
may
associ
increas
cardiovascular
risk
vanadium
complex
consid
drug
deliveri
system
present
better
therapeut
effect
classic
inorgan
vanadium
salt
observ
vivo
studi
evalu
antihyperglycem
activ
also
insulinmimet
activ
perform
vitro
insulinmimet
effect
exert
vanadium
compound
may
attribut
stimul
autophosphoryl
insulin
receptor
howev
depend
anim
tissu
speci
studi
exampl
rat
lung
cell
rabbit
cell
autophosphoryl
insulin
receptor
could
determin
hand
insulinmimet
effect
vanadium
compound
due
stimul
kinas
enzym
translat
signal
use
insulin
mapk
protein
respons
regul
metabol
mitogen
effect
insulin
addit
inhibit
due
administr
vanadium
complex
activ
signal
akt
increment
tyrosin
phosphoryl
irb
ir
tyrosin
phosphoryl
result
suggest
fact
inhibit
ptpase
especi
tyrosin
phosphatas
main
mechan
insulinmimet
effect
certain
vanadium
compound
behav
revers
inhibitor
compound
perform
irrevers
inhibit
modifi
protein
due
redox
process
lu
et
al
show
treatment
vanadium
glutam
complex
na
v
v
glu
ch
oh
abl
inhibit
human
vitro
also
type
ptp
src
homolog
phosphatas
hematopoiet
tyrosin
phosphatas
heptp
tcell
protein
tyrosin
phosphatas
tcptp
inhibitori
activ
attribut
largest
complex
form
physiolog
ph
establish
neg
regul
insulininduc
glucos
metabol
inhibit
phosphatas
increas
glucos
uptak
enhanc
insulin
receptor
signal
oxovanadium
iv
complex
shown
inhibitori
effect
suggest
compound
na
vo
glu
ch
oh
amino
benzoatodiaquaoxovanadium
iv
play
import
role
enzym
select
bisperoxovanadium
compound
describ
inhibitor
pten
anoth
import
counterregul
insulin
signal
howev
inhibit
vanadium
complex
amino
acid
demonstr
vanadium
compound
studi
antidiabet
insulinomimet
agent
also
treatment
parasit
diseas
tropic
origin
cancer
protector
tissu
damag
induc
chemic
agent
oxid
stress
vanadium
compound
vanadylsulph
sodium
vanad
peroxidovanad
shown
antitumor
activ
experiment
model
vitro
vivo
vanadocen
dichlorid
vanadium
iii
lcystein
complex
complex
metvan
v
iv
vanadium
complex
flavonoid
polyphenol
semicarbazon
deriv
vanadiumschiff
base
complex
demonstr
antitumor
properti
studi
differ
type
cell
line
inhibit
cell
prolifer
throughout
rang
concentr
studi
chemic
structur
differ
vanadium
compound
antitumor
activ
shown
fig
inorgan
vanadium
vanadium
complex
lead
cell
apoptosi
classic
intracellular
event
cell
cycl
arrest
dissip
mitochondri
membran
potenti
induct
mitochondri
permeabl
transit
pore
cytochrom
c
releas
activ
proapoptot
protein
activ
caspas
dna
fragment
format
apoptot
bodi
lead
cell
death
mediat
activ
variou
signal
molecul
mapk
nfkb
reactiv
oxygen
speci
ro
possibl
key
protein
effect
vanadium
compound
sinc
larg
number
tumor
cell
defect
gene
encod
protein
case
mous
embryo
fibroblast
vanad
inhibit
cell
cycl
induc
apoptosi
wherea
function
cell
vanad
promot
phase
favor
prolifer
ammonium
monovanad
abl
induc
apoptosi
rat
breast
cancer
anthracen
induc
cell
cultur
accompani
strong
express
report
induc
apoptosi
human
pancreat
ductal
adenocarcinoma
mechan
involv
ro
increas
although
evid
suggest
antineoplast
action
vanadium
compound
partli
due
inhibit
cellular
mechan
complex
involv
significantli
increas
oxid
stress
noteworthi
inhibit
carri
direct
union
compound
posttransl
modif
induc
reactiv
oxygen
speci
inhibitori
process
involv
rosinduc
oxid
cystein
within
activ
site
abrog
nucleophil
function
role
cancer
extens
investig
recent
determin
increas
express
enzym
contribut
robustli
develop
type
tumor
especi
breast
cancer
vanadium
complex
oxodiperoxo
vanad
pvphen
oxidovanadium
iv
complex
oxodiacet
oda
bipyridyl
vo
oda
bipi
ophenanthrolin
vo
oda
phen
v
v
peroxidobetain
metvan
well
v
iii
lcystein
shown
close
link
antitumor
activ
increas
product
ro
variou
cancer
line
metvan
success
vanadium
complex
test
antitumor
concentr
rang
lm
induc
cell
apoptosi
differ
tumor
line
leukemia
cell
multipl
myeloma
cell
breast
prostat
ovarian
testicular
cancer
cell
demonstr
high
effici
compar
cisplatin
dual
role
vanadium
complex
manifest
synthesi
vanadium
complex
phenol
compound
flavonoid
wide
known
type
natur
product
antioxid
cytotox
chemosensit
properti
among
outstand
complex
naringenin
morin
chrysin
silibinin
late
shown
vanadium
compound
also
chemoprevent
effect
sinc
chelat
compound
may
signific
effect
improv
antioxid
antitumor
properti
flavonoid
aim
fact
synthes
v
iv
flavonoid
morin
silibinin
prove
line
cell
studi
osteosarcoma
gave
promis
result
vanadium
compound
deriv
antitumor
properti
induc
cell
death
apoptosi
ic
valu
lower
cisplatin
import
mention
privileg
structur
present
mani
natur
product
use
pharmacophor
design
compound
biolog
activ
differ
type
neurodegen
diseas
herp
enhanc
bioavail
vanadium
complex
increas
abil
penetr
lipidrich
cell
membran
evangel
et
al
demonstr
vanadium
iii
lcystein
abl
decreas
rate
tumor
growth
therebi
surviv
benzo
pyreneinduc
cancer
rat
fact
amino
acid
vanadium
complex
exhibit
much
greater
potenc
vanadylsulph
benzo
pyreneinduc
leiomyosarcoma
wistar
rat
interestingli
solut
vanadium
iii
lcystein
ph
approx
lm
show
cytotox
effect
hepatoma
cell
reduc
cell
viabil
concentr
mm
vanadium
speci
concentr
cultur
medium
howev
state
proton
cystein
coordin
metal
center
report
clear
speci
respons
effect
paper
note
liver
cancer
consid
one
aggress
metastat
limit
therapeut
altern
great
import
studi
new
antineoplas
type
cancer
vanadium
iii
lcystein
main
complex
amino
acid
antineoplast
activ
organovanadium
better
profil
combin
therapi
anticanc
agent
howev
biotransform
type
complex
intim
molecular
mechan
biolog
effect
exert
unknown
recent
establish
aspect
cellular
molecular
mechan
vanadium
iii
lcystein
complex
murin
model
breast
cancer
complex
show
decreas
tumor
volum
abl
activ
proapoptot
signal
involv
dissip
mitochondri
membran
potenti
induct
bax
releas
mitochondri
cytochrom
c
activ
caspas
induct
express
dna
fragment
well
inhibit
antiapoptot
protein
treatment
v
iii
lcystein
complex
prepar
increas
antineoplast
effect
cyclophosphamid
mice
implant
breast
cancer
cell
also
increas
effect
cisplatin
human
breast
cancer
lung
cancer
cell
line
respect
antitumor
chemosensit
effect
complex
accompani
import
antiangiogen
antimetastat
activ
v
iii
lcystein
decreas
level
vascular
endotheli
growth
factor
vegfa
matrix
metalloproteinas
induc
angiogenesi
metastasi
respect
inhibit
reduct
metalloproteinas
vitro
suggest
mechan
may
link
antimetastat
activ
observ
vivo
work
papaioann
complex
vanadium
cystein
includ
v
iv
olcystein
methyl
ester
abl
protect
nonneoplast
cell
cyclophosphamideinduc
toxic
produc
revers
increas
ro
nitric
oxid
transaminas
well
enhanc
activ
antioxid
enzym
catalas
superoxid
dismutas
glutathion
peroxidas
liver
experiment
anim
addit
chemoprotect
v
iv
olcystein
methyl
ester
cisplatin
cyclophosphamideinduc
toxic
establish
bone
marrow
cell
lymphocyt
decreas
dna
fragment
apoptosi
chromosom
aberr
current
known
cystein
complex
exhibit
protect
effect
renal
damag
cisplatininduc
mice
oxid
stress
reduct
antioxid
statu
restor
play
critic
role
fig
show
summari
possibl
mechan
action
antitumor
activ
v
iii
lcystein
complex
natur
ligand
may
play
import
role
select
potenc
type
biolog
activ
exert
vanadium
complex
case
amino
acid
ligand
may
addit
effect
interest
lcystein
known
chemoprotector
amino
acid
report
produc
contribut
antitumor
effect
excel
exampl
repres
glycin
studi
antiinflammatori
cytoprotect
properti
brun
et
al
show
glycin
inhibit
angiogenesi
human
hepatocellular
carcinoma
cell
cultur
decreas
vegfa
express
howev
vanadium
complex
glycin
glycin
shown
antineoplast
activ
vanadium
n
acetophenon
glycin
shown
import
cytotox
effect
human
tcell
acut
lymphoblast
leukemia
human
colorect
carcinoma
human
breast
cancer
human
astrocytoma
cell
line
without
show
toxic
effect
normal
fibroblast
cell
line
mice
likewis
mice
cancer
induc
ehrlich
cell
ascit
carcinoma
sarcoma
cell
transplant
complex
abl
decreas
tumor
surviv
although
toxic
vanadium
well
known
vanadium
complex
glycin
present
low
toxic
experiment
anim
differenti
toxic
vanadium
speci
complex
biotransform
product
must
studi
thoroughli
defin
mechanist
toxicolog
vanadium
compound
recent
shown
human
colorect
carcinoma
cell
vanadium
n
acetophenon
glycin
induc
apoptosi
mechan
includ
mitochondri
damag
dna
damag
increas
ro
select
vanadium
compound
neoplast
cell
vs
normal
cell
describ
howev
normal
hepat
cell
cultur
sodium
metavanad
bi
acetylacetonato
oxovana
dium
iv
bi
maltolato
oxovanadium
iv
ro
increas
compar
hepatoma
cell
possibl
type
vanadium
compound
may
abl
mitig
toxic
effect
anticanc
agent
healthi
cell
suggest
cysteinecontain
compound
might
promis
vanadium
complex
chemosensit
chemoprotect
function
promis
use
combin
therapi
anoth
import
mechan
vanadium
compound
also
exhibit
antiprolif
cytotox
effect
might
interact
dna
either
interact
dna
nucleotid
phosphat
group
propos
case
vanadocen
complex
direct
intercal
dna
vanadium
complex
acid
hydrazid
vo
pahn
phen
result
increas
ro
oxid
dna
damag
vanadecen
complex
nonessenti
amino
acid
report
literatur
prolin
glycin
howev
unknown
whether
class
complex
produc
antitumor
effect
whether
capabl
interact
genet
materi
also
import
mention
drugreceptor
interact
biolog
system
may
due
revers
irrevers
interact
vanadium
compound
amino
acid
protein
case
vanadium
haloperoxidas
complex
form
vanadium
histidin
exampl
vanad
v
ion
coordin
histidin
residu
nodosum
bromoperoxidas
reason
mani
vanadium
complex
report
literatur
order
simul
mode
coordin
histidin
residu
vanadium
compound
also
test
parasit
diseas
therapeut
target
compound
trypanosoma
cruzi
leishmania
spp
entamoeba
histolytica
caus
trypanosomiasi
leishmaniasi
amoebiasi
respect
avail
drug
market
parasit
present
well
toxic
side
effect
parasit
respons
diseas
develop
rapid
resist
activ
drug
reason
import
develop
newer
therapeut
arsen
diseas
inclus
metal
center
antiparasit
drug
improv
pharmacolog
properti
format
metal
complex
serv
modul
activ
possibl
drug
strategi
use
sanofiaventi
develop
ferroquin
first
organometal
drug
potenti
antimalari
activ
polypyridyl
ligand
relev
search
new
therapeut
agent
parasit
diseas
key
mechan
action
vanadium
compound
antiparasit
activ
may
result
either
intercal
phen
moieti
complex
dna
inhibit
specif
parasit
enzym
metal
center
mechan
involv
synergist
effect
metal
phen
ligand
vitro
studi
antit
cruzi
activ
demonstr
depend
mainli
natur
ligand
follow
order
increas
activ
found
chemic
structur
polypyridyl
ligand
capabl
intercal
dna
shown
fig
chaga
diseas
american
trypanosomiasi
evalu
compound
v
iv
l
l
wherein
l
repres
bident
polypyridyl
ligand
wherea
l
correspond
salicylaldehyd
semicarbazon
deriv
spectroscop
character
show
ligand
semicarbazon
occupi
equatori
posit
around
distort
octahedr
geometri
biolog
activ
compound
could
due
interact
dna
biomolecul
activ
compound
show
signific
vitro
activ
cruzi
refer
drug
nifurtimox
wherea
molecular
dock
studi
show
biolog
activ
present
explain
dna
interc
mechan
metallo
drug
hand
seri
compound
formul
vo
phen
evalu
l
panamensi
l
chaga
promastigot
intracellular
amastigot
decavanad
compound
nh
v
also
shown
inhibitori
activ
vitro
l
tarentola
promastigot
influenc
growth
leishmania
spp
probabl
due
inhibit
phosphatas
suggest
effici
certain
vanadium
compound
antiparasit
activ
due
easi
consumpt
cell
effici
toward
certain
target
phen
molecul
exampl
might
te
relev
drug
activ
improv
metal
center
dna
intercal
capabl
characterist
might
relev
factor
addit
vanadium
compound
may
undergo
ligand
exchang
reaction
produc
newer
speci
may
contain
origin
ligand
anoth
promis
therapeut
applic
vanadium
compound
refer
antivir
action
vanadiumthiourea
vanadium
polyoxotungstenesubstitut
compound
shown
potent
antihiv
activ
toward
infect
cell
particular
v
iv
v
v
sbw
exhibit
antivir
activ
fig
chemic
structur
polypyridin
ligand
capabl
intercal
dna
modifi
ref
also
shown
vitro
activ
influenza
dengu
fever
sever
acut
respiratori
syndrom
sar
compound
decompos
vanad
v
tungsten
vi
seem
true
activ
speci
v
iv
oporphyrin
complex
also
shown
inhibitori
effect
evalu
replic
cell
complex
show
antivir
activ
compar
vehicl
control
effect
porphyrin
complex
stabil
metal
center
unstabl
physiolog
ph
addit
make
complex
oxidovanadium
iv
porphyrin
solubl
aqueou
media
avoid
demetal
reaction
one
main
goal
antihiv
drug
revers
transcriptas
oxidovanadium
iv
porphyrin
compound
revers
transcriptas
min
incub
bind
protein
energi
kcal
mol
way
prevent
viru
enter
host
cell
activ
v
iv
oporphyrin
complex
measur
use
elisa
method
chemic
structur
oxidovanadium
iv
porphyrin
complex
shown
fig
current
effort
made
improv
biotransform
possibl
metallodrug
gastrointestin
tract
target
cell
sinc
mani
candid
compound
unstabl
gastrointestin
ph
less
vanadium
absorb
oral
dose
addit
research
focus
reduc
gastric
irrit
improv
blood
transport
studi
possibl
inflammatori
reaction
cellular
level
sinc
vanadium
compound
increas
product
ro
reactiv
nitrogen
speci
rn
multipl
mechan
blood
plasma
bloodprotein
apotransferrin
apotf
albumin
hsa
interact
exampl
vanad
anion
v
cation
speci
v
iv
neutral
charg
v
iv
ol
speci
serv
transport
import
note
therapeut
purpos
essenti
know
oxid
state
vanadium
transport
blood
plasma
realli
import
know
biodistribut
vanadium
although
knowledg
form
metal
ion
fundament
target
cell
vanadium
enter
either
form
bloodstream
bound
plasma
protein
allow
uptak
distribut
intern
tissu
heart
liver
kidney
extern
tissu
brain
muscl
adipos
tissu
first
h
vanadium
content
blood
reduc
wherea
within
erythrocyt
vo
reduc
vo
partial
releas
genuin
drug
capabl
bind
hemoglobin
hb
coordin
intact
complex
histidin
residu
suggest
vo
maltol
hb
complex
analog
situat
occur
vo
picolin
fig
seen
differ
metabol
pathway
vanadium
organ
vanadiumbas
drug
may
consum
oral
encapsul
avoid
therefor
potenti
alter
compound
due
strongli
acid
condit
stomach
import
result
report
sakurai
et
al
evalu
differ
form
oral
applic
oxidovanadium
complex
order
replac
insulin
inject
insulindepend
patient
two
differ
method
oral
administr
vanadyl
complex
evalu
includ
complex
capsul
pharmacokinet
studi
show
entericco
capsul
increas
bioavail
activ
oxidovanadium
speci
way
vanadium
incorpor
applic
intraven
inject
inhal
etc
vanadium
compound
enter
contact
blood
plasma
compon
suffer
seri
ligand
exchang
reaction
compound
mainli
compon
low
molecular
mass
citrat
lactat
high
molecular
weight
ligand
transferrin
albumin
immunoglobulin
g
chang
oxid
state
metal
may
also
occur
exampl
reduc
agent
ascorb
glutathion
nadh
reduc
v
v
v
iv
even
v
iii
oxid
agent
nad
convert
v
iv
v
v
observ
throughout
review
chemistri
vanadium
especi
interact
amino
acid
well
studi
demonstr
import
metal
industri
biochem
pharmacolog
level
bioinorgan
point
vanadium
shown
essenti
correct
biolog
function
limit
number
organ
enzym
vanadium
nitrogenas
vanadatedepend
haloperoxidas
vanadium
compound
also
show
potenti
applic
medic
field
especi
regard
treatment
diabet
cancer
vanadium
complex
lglutam
lcystein
respect
establish
interest
window
discoveri
new
drug
addit
sever
vanadium
complex
essenti
nonessenti
amino
acid
shown
better
safeti
profil
preclin
studi
suggest
compound
may
less
toxic
inorgan
vanadium
compound
howev
efficaci
safeti
vanadium
complex
potenti
metallodrug
investig
thoroughli
author
present
manuscript
consid
research
area
focus
vanadium
chemistri
continu
develop
obtain
new
compound
direct
impact
inorgan
medicin
chemistri
find
report
literatur
suggest
use
amino
acid
deriv
vanadium
ligand
highli
promis
biomolecul
high
biochem
physiolog
nutrit
valu
also
benefici
therapeut
potenti
exert
import
number
author
present
articl
dedic
memori
professor
dr
felip
brito
consid
father
solut
chemistri
venezuela
contribut
develop
chemistri
throughout
year
scientif
career
countri
